Chugai Pharmaceutical Co., Ltd. stock is traded under the ticker #4519. Below you can review Chugai Pharmaceutical Co., Ltd. stock performance in the past 12 months up to July 2026

Total visits to Chugai Pharmaceutical Co., Ltd.'s top domains

Understand Chugai Pharmaceutical Co., Ltd. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

chugai-pharm.co.jp311.8K

See more with Sales Intelligence

Avg. visit duration in Chugai Pharmaceutical Co., Ltd.'s top domains

Analyze Chugai Pharmaceutical Co., Ltd. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

chugai-pharm.co.jp00:01:27

See more with Sales Intelligence

Avg. pageviews on Chugai Pharmaceutical Co., Ltd.'s top domains

See how Chugai Pharmaceutical Co., Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

chugai-pharm.co.jp2.65

See more with Sales Intelligence

Chugai Pharmaceutical Co., Ltd. top competitors by domain

Top similar sites in July 2026, ranked by their affinity

kyowakirin.co.jpCompany NameKyowa Kirin Co., Ltd.Employees5001 - 10000HQJapan, OtemachiAnnual revenue> $1BTotal visits186.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Chugai Pharmaceutical Co., Ltd.

These are the website technologies, by industry, used by Chugai Pharmaceutical Co., Ltd. top domains

Payment & Currencies (22)

PayPal

Conversion & Analytics (6)

Google Analytics

Advertising (3)

Google Adsense

Social (3)

Instagram

More Technologies

9

See all

News & Signals from Chugai Pharmaceutical Co., Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsChugai Group is developing anti-dengue antibody on Aug 19th '26.Chugai Pharmaceutical and GSK are deepening their partnership on an anti-dengue antibody (AID351) targeting all four dengue virus serotypes.

NewsChugai Group partnered with GlaxoSmithKline plc on Aug 18th '26.Japanese drugmaker Chugai Pharmaceuticals (TYO: 4519), which is majority owned by Swiss pharma giant Roche (ROG: SIX), announced that it has signed an exclusive license agreement with the UK's GSK (LSE: GSK) for the anti-dengue virus antibody AID351.

NewsChugai Group partnered with UCSF Health, AG on Aug 7th '26.Chugai and UCSF establish Master Collaboration Agreement for drug discovery research - A framework to streamline future research projects-.